UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Search results for:

ocrelizumab

ocrelizumab
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Ocrelizumab (Ocrevus) SOLUTION, INTRAVENOUS 30 mg/mL (10 mL)            
Ocrelizumab-Hyaluronidase SOLUTION, SUBCUTANEOUS 40 mg-1000units/mL (920 mg/23,000 units/23 mL))                

UNC Health

     System Formulary Restriction:

     Use of ocrelizumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)

     UNC Health IV Compendium Guideline

Med Center
     UNC Medical Center Formulary Restrictions


Last updated: May. 28, 2025







This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.